NEW YORK, Dec. 11, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nanorobotics space, today announced that it is experiencing very strong levels of international interest for the commercialization of Pilus Energy LLC's ("Pilus Energy") proprietary wastewater-to-value BactoBot™ ("the technology"). The Company was approached by a number of potential exclusive licensees and joint venture partners, interested in commercializing Pilus Energy's technology platform in specific countries and jurisdictions. Several of these potential partnerships are now in late stage negotiations and represent an outstanding opportunity for the Company to generate revenue and penetrate global markets effectively and efficiently. These potential international industry partners and licensees are discovering the technology through attendance at Company investor presentations, recent media exposure, and the recently announced crowd funding campaign. The interested parties in negotiations with Tauriga represent countries, regions, and jurisdictions including: Southeast Asia, the Middle East, Central Europe, the Far East, North America, and Scandinavia.
Tauriga's Chief Executive Officer, Seth M. Shaw, commented, "The levels of interest that we are experiencing from across the globe have been extremely encouraging. There is clearly an important role in the global economy for Pilus Energy's technology platform and we are being discovered and contacted by industry players who are excited about our future. The company is pleased with the progress being made in its capital raising efforts and is working extremely hard to complete the acquisition of Pilus Energy in a timely manner."
In other news, Tauriga Sciences Inc. will be presenting today at 4:30 pm CET or 10:30 am EST at the World Resource Ventures 2013 Clean-Tech Investor Conference ("the conference") at the Konrad-Adenauer-Foundation, located at Tiergartenstrasse 35, Berlin, Germany. The presentation, being delivered by Tauriga's CEO, will be digitally recorded and added to the Company's corporate website as soon as practicable.
Lastly the Company wished to congratulate its strategic partner Bacterial Robotics LLC on being awarded a $150,000 USD National Science Foundation ("NSF") grant. Please read the following link to learn more: ( http://www.wcpo.com/money/local-business-news...tion-grant ).
On November 25, 2013, the Company signed a definitive agreement to acquire Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Upon consummation of the proposed reverse merger, which has been unanimously ratified by Tauriga's board of directors, Pilus Energy will become a wholly-owned subsidiary of Tauriga.
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at ( www.tauriga.com ).
About Pilus Energy LLC
A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). For more information, please visit Pilus Energy's web site, ( www.pilusenergy.com ).
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
For further information regarding Tauriga Sciences, Inc.: Mr. Seth M. Shaw Chairman & Chief Executive Officer Tauriga Sciences, Inc. www.tauriga.com New York: +1-917-796-9926 Montreal: +1-514-840-3697 Email:
